ABEONA THERAPEUTICS INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ABEONA THERAPEUTICS INC. stock issued during period, value, issued for services for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- ABEONA THERAPEUTICS INC. stock issued during period, value, issued for services for the quarter ending 2016-09-30 was $2.45M, a 454.75% increase year-over-year.
- ABEONA THERAPEUTICS INC. stock issued during period, value, issued for services for the quarter ending 2015-12-31 was $401.00K.
- ABEONA THERAPEUTICS INC. stock issued during period, value, issued for services for the quarter ending 2015-09-30 was $442.00K.
- ABEONA THERAPEUTICS INC. stock issued during period, value, issued for services for fiscal 2016 was $2.45M, a 511.47% increase from fiscal 2015.
- ABEONA THERAPEUTICS INC. stock issued during period, value, issued for services for fiscal 2015 was $401.00K, a 14.90% increase from fiscal 2014.
- ABEONA THERAPEUTICS INC. stock issued during period, value, issued for services for fiscal 2014 was $349.00K, a 214.41% increase from fiscal 2013.
- ABEONA THERAPEUTICS INC. stock issued during period, value, issued for services for fiscal 2013 was $111.00K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $2.45M 10-K · filed 2019-03-18 |
| 2016-09-30 | $2.45M 10-Q · filed 2016-11-14 | |
| 2015-12-31 | $401.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $401.00K 10-K · filed 2017-03-30 |
| 2015-09-30 | $442.00K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $75.00K 10-Q · filed 2015-11-16 | |
| 2015-03-31 | $87.00K 10-Q · filed 2015-11-16 | |
| 2014-12-31 | $349.00K 10-K · filed 2016-03-30 | |
| 2013-12-31 | $111.00K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |